The ␤-selection checkpoint in ␣␤T lymphocyte development occurs at the double negative (DN) 3 (CD4 ؊ CD8 ؊ CD25 ؉ c-kit ؊ ) stage, when further differentiation requires a signal from the newly rearranged TCR ␤ chain. Thymocytes with mutations in key signaling molecules in the phosphatidylinositol 3-kinase-Akt pathway manifest defects in survival, proliferation, and differentiation past the ␤-selection checkpoint. However, little information is available regarding the role of Akt itself in thymocyte development. In this study, we explore the role of the two Akt isoforms most highly expressed in the thymus, Akt1 and Akt2, in early T cell development. Using several complementary approaches, we find that deletion of Akt1 results in only minor defects in thymocyte development. The Akt1 ؊/؊ Akt2 ؊/؊ thymocytes manifest a severe developmental block at the DN3 stage and ultimately fail to repopulate the T cell compartment of an irradiated host. Further, we show that Akt1 ؊/؊ Akt2 ؊/؊ DN3 cells have decreased glucose uptake and die in response to TCR stimulation in vitro. Study of thymocytes from the genetically altered mice suggests that the cause of the developmental defect is due to apoptosis, partially caused by decreased cellular growth and metabolism at the DN3 stage. Our results show that Akt protects thymocytes from cell death during the ␤-selection checkpoint.
T cell development is a tightly regulated process that is not only a model for other developmental systems but also provides insight into the biological outcomes of T cell signaling. ␣␤T lineage development begins with the emigration of multipotent progenitors to the thymus (1) . During development, progeny of these émigrés transit through four subsets as CD4 Ϫ CD8 Ϫ [double negative (DN)] cells, before expressing both CD4 and CD8 at the double positive (DP) stage. The four DN subsets are defined by surface expression of CD117 (c-kit), CD44, and CD25. Cells at the DN3 (CD4 Ϫ CD8 Ϫ CD25 ϩ c-kit Ϫ ) stage are c-kit lo CD44 Ϫ CD25 ϩ , then down-regulate CD25 as they become DN4 cells (2) . A critical event during the DN3 stage is VDJ rearrangement at the T cell receptor (TCR) ␤ chain loci. The pre-TCR is composed of this rearranged ␤ chain and the pre-T␣. DN3 cells successfully pass ␤-selection only with intact pre-TCR signals, and thymocytes that lack the pre-TCR or key signaling molecules fail ␤-selection, arrest at the DN3 stage, and undergo death by neglect (3) . In contrast, successful pre-TCR signaling initiates four processes: a proliferative burst to replicate those cells that have successfully rearranged a TCR ␤-chain, an anti-apoptotic signal to counteract death by neglect, allelic exclusion to ensure clonality in the mature T cell population, and differentiation to the DP stage (2) .
The protein products of the three members of the mammalian Akt gene family (Akt1, Akt2, Akt3) play important roles in cell growth and survival (4) . All three isoforms are similar in structure, are activated in a phosphatidylinositol 3-kinase (PI3K)-dependent manner, and likely share multiple downstream targets. The individual Akt isoforms are expressed in a tissue-specific manner, with Akt1 and Akt2 ubiquitously expressed and Akt3 more highly expressed in the brain and testes (5) . All three isoforms are able to compensate for each other in some common pathways; however, recent work indicates that they may also play unique roles when expressed concurrently (6) . The biological outcomes of Akt activation vary widely and depend on the developmental stage and cell type. In mature ␣␤T cells, Akt is rapidly phosphorylated upon engagement of the TCR and the co-stimulatory receptor CD28, causing an increase in the metabolic activity of the dividing cells (7) . Stimulated T cells up-regulate cell metabolism through an Akt-mediated pathway by increasing total expression and cell surface trafficking of Glut1, the primary glucose transporter in hematopoietic cells (8) . Akt has also been shown to regulate metabolism in DN3 T cells (9) . Because pre-TCR signaling is required for developmental progression during thymopoiesis, we hypothesized that Akt would also play an important role in T cell development.
Survival, differentiation, and proliferation during the DN3 to DP transition are regulated by molecular signals downstream of the pre-TCR, Notch, and cytokine receptors (2) . We predicted that the Akt signaling pathway would be involved at the DN3-DP transition, because an upstream activator of Akt, PI3K (10) , and a downstream effector of Akt, Bcl-xL (11), have both proven to be important in T cell development. In this article, we use a genetic loss-of-function approach to demonstrate that Akt1 and Akt2 are required for efficient maturation of DN3 thymocytes to the DP stage of T cell development. Our data further suggest that although the loss of Akt reduces thymocyte metabolism, the predominant defect observed in the Akt-deficient cells is on survival in response to pre-TCR engagement.
its phosphorylation by mTOR/Rictor and PDK1 (4). We found that direct stimulation of the TCR in thymocytes results in the rapid phosphorylation of Akt (Fig. 1C) . To ascertain whether the loss of individual Akt isoforms would affect thymic development, we analyzed T cell subsets from mice with targeted deletions of either Akt1 or Akt2 [supporting information (SI) Fig. 7 ]. The overall thymic cellularity of adult Akt1 single knockout mice was consistently decreased compared with heterozygous littermates, but this did not affect the distribution of immature thymocytes or translate to altered peripheral T cell subsets (SI Fig. 7 ). Although there were fewer thymocytes present in the setting of Akt1 deficiency, loss of either Akt1 or Akt2 did not markedly affect thymocyte subsets or activation of mature T cells (data not shown).
To address the possibility that the lack of a developmental phenotype in the Akt-deficient mice was due to compensation by other isoforms, we next studied the T cell compartment when both Akt1 and Akt2 were eliminated. These experiments were challenging because Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ mice die within a few hours of birth (12) . Therefore, we made use of three complementary approaches: fetal thymic analysis to investigate the earliest stages of development, the OP9-DL1 coculture system to model further development ex vivo, and fetal liver bone marrow chimeras to assess full thymic development and the appearance of peripheral T cells. We first analyzed thymi from embryos and newborn pups. Consistent with our findings from adult single knockout mice, Akt1
Ϫ/Ϫ embryos had consistently lower thymic cellularity. This lower cellularity did not result in significantly altered thymic subsets (Fig. 2) . In contrast, the loss of Akt1 and Akt2 caused both a reduction in thymocyte cellularity and altered T cell subsets (Fig. 2) .
Decreased numbers of thymic progenitors may have affected later development in the absence of Akt1 and Akt2. Analysis of the early thymocyte progenitor (1) and DN2 populations showed no significant difference between Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ embryos and littermate controls (data not shown). In contrast, the total number of DN3 cells in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymus was decreased 2-fold compared with controls (SI Fig. 8A ). Furthermore, the number of DN4 cells in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ fetal thymus was reduced Ϸ4-to 5-fold compared with heterozygous controls (Fig. S2 A) . The increased DN3:DN4 ratio is consistent with a partial block at the DN3 stage (SI Fig. 8B ). It remained unclear whether the altered thymic development found in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ fetal thymus was due to delayed transition time from the DN3 to DP stage, decreased survival within or past the DN3 stage, or a secondary effect from Akt loss in the thymic stroma. To address the first possibility, we used the OP9-DL1 coculture model (13) to ask whether Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DN3 cells would differentiate to the DP stage if allowed a lengthier period than allowed by the short fetal lifespan. Fetal liver-derived progenitor cells from knockout embryos were cultured on OP9-DL1 monolayers for 21 days. We did not observe a defect in development before the DN3 stage, measured at day 10, in cultures from mutant embryos (data not shown). However, after 13 days of culture, there was a 33-fold reduction in the frequency of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ cells that up-regulated CD4 or CD8 compared with the Akt1 ϩ/Ϫ Akt2 ϩ/ϩ control ( Fig. 3) . Next, we continued the OP9-DL1 cultures for 7 days to determine whether the developmental defect was due to a delayed transition time. By day 21, 60% of the cells in Akt1
Akt2 ϩ/ϩ control cultures were positive for either CD4 or CD8, but less than 1% of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ cells became CD4 or CD8 positive (data not shown). Cells that had only one WT allele of either Akt1 or Akt2 displayed an intermediate phenotype. Collectively, the in vivo fetal thymic data and the in vitro OP9-DL1 coculture data demonstrate a partial defect at the ␤-selection checkpoint that is not caused by altered thymic stroma. Population of an Irradiated Host. Although the OP9-DL1 coculture system provides an excellent model for thymic development, this approach can only recapitulate a subset of the environmental cues that thymocytes normally receive in vivo. To measure T cell development in a more physiological setting, fetal liver cells were transferred to lethally irradiated congenic hosts. Analysis of the thymi 7-8 weeks after reconstitution revealed that Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes could differentiate to the DP and SP stages, but, consistent with our results in the fetal thymus and in OP9-DL1 co-cultures, there was a lower percentage of cells in the DP stage and a higher percentage of cells at the DN3 stage (Fig. 4A ). Overall thymic cellularity in reconstituted chimeras was decreased 2-fold with the single loss of either Akt1 or Akt2 but decreased 45-fold with deficiency of both Akt1 and Akt2 (Fig. 4B) . Analysis of thymic subsets revealed that the number of DN3 cells was 2-fold lower in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras compared with the controls. The absence of a single isoform of Akt resulted in a 2-fold reduction in the DP population (Fig. 4B) . In contrast, the total number of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DP cells was decreased 70-fold compared with the control (Fig. 4B) . The CD8 SP cells in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras were mostly immature SPs, a step before the DP stage marked by low TCR␤ levels and high CD24 expression (data not shown).
We next analyzed the peripheral T cell compartment to determine whether the few remaining Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ SP thymocytes could exit the thymus as mature T cells. Overall splenic cellularity was decreased 2-fold in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras with decreases in both the B220 ϩ population and the Thy1.2 ϩ populations ( Fig. 4C and SI Fig. 9 ). However, T cells were more affected than B cells, and the ratio of Thy1.2 ϩ cells to B220 ϩ cells was decreased in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras (SI Fig. 9 ), possibly because of the higher expression of Akt3 in B cells than in T cells (Fig. 1 A) . CD4 ϩ and CD8
ϩ cells respond differently to altered signals in the thymus, and the current model suggests that stronger or longer TCR signals favor the CD4 ϩ lineage and weaker or shorter TCR signals direct cells to the CD8 ϩ lineage (14) . Therefore, as might be expected, we found that the CD4 ϩ lineage was more affected than the CD8 ϩ lineage in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras, as manifested by a decreased ratio of CD4 ϩ to CD8 ϩ cells (SI Fig. 9 ). The decreased cellularity in the periphery did not affect all hematopoietic lineages equally, as no significant decrease in ␥␦T cells, Mac-1 ϩ Gr-1 ϩ neutrophils, or NK1.1 ϩ NK cells was observed (SI Fig. 9 ). The normal development of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ ␥␦T cells is further evidence that the DN stages are not as affected by the loss of Akt1 and Akt2, because the ␥␦T lineage is thought to diverge from the ␣␤T lineage before the DP stage (15) .
Akt1 ؊/؊ Akt2 ؊/؊ Thymocytes have Decreased Glucose Uptake. The reduction in DP cells in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras could be due to either an increase in cell death or a decrease in the generation of DP cells. Because the 2-fold decrease in DN3 cells was not sufficient to explain the 70-fold decrease in DP cells, we first examined the metabolic capacity of DN3 cells by measuring the transport of glucose into the cell in vitro. Glucose uptake is a necessary step to sustain cell survival and metabolism for subsequent growth and division (16) , and Akt has been shown to require glucose metabolism to prevent cell death (13) . Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DN3 cells had reduced glucose uptake in vitro compared with controls (Fig. 5A) . We consistently found that the glucose uptake relative to the total Glut1 receptor expression (data not shown) was reduced in Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ cells, suggesting a requirement for these isoforms for efficient glucose transport in developing thymocytes.
Cellular metabolism is linked to cell size and overall protein content. Further, the activation of the Akt/mTOR pathway is critical for cell size determination (4). Consistent with this role for Akt, transgenic expression of myr-Akt in T cells results in an approximate 10% increase in cell size (17) . Conversely and in support of our finding that glucose uptake was altered, we also found that Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DN3 cells were reduced in size by 10% compared with heterozygous controls (SI Fig. 10A ). Further, Akt1
Ϫ/Ϫ Akt2 Ϫ/Ϫ DN3 cells lost a greater volume of their cell size with growth factor deprivation compared with controls (Fig. 10B) .
Akt has a positive effect on proliferation in many model systems including peripheral T cells (4) . During normal thymocyte development, CD25 is diluted from the surface as cells undergo multiple divisions to the DP stage, and thymocytes that have proliferative defects abnormally retain CD25 at the DP stage (18) . We found that Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DP thymocytes retain surface CD25 (data not shown). To investigate more directly whether proliferation is altered in Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes, bone marrow chimeras were pulsed with BrdU in vivo (Fig. 5 B  and C) . We found no difference in the overall percentage of 
thymocytes in S phase in Akt1
Ϫ/Ϫ Akt2 Ϫ/Ϫ chimeras compared with controls (Fig. 5B) . Because the formation of a pre-TCR regulates entry into the cell cycle, we also measured whether BrdU ϩ cells were also TCR␤ ϩ . The combined loss of Akt1 and Akt2 does not alter the percentage of total thymocytes that are intracellular (ic)TCR␤ ϩ and BrdU ϩ compared with WT controls (Fig. 5C ), although, a careful subset analysis suggested a modest defect in proliferation within the CD4 Ϫ CD8-TCR␤ ϩ population. These data indicate that loss of Akt1 and Akt2 does not preclude the proliferative response to pre-TCR signaling.
Defective Development Beyond the DN3 Stage Is Due to Increased
Apoptosis in Akt1 ؊/؊ Akt2 ؊/؊ Mice. Previous work reported increased DP thymocyte survival in transgenic mice that express myr-Akt1 in T cells (19) . Myr-Akt1 was found to increase expression of Bcl-xL (19) ; however, we did not detect any alteration in Bcl-xL expression level in Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes relative to controls (data not shown). To complement the gain-of-function experiment, we analyzed Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes from chimeras and newborn pups for the frequency of spontaneously apoptotic cells (Fig. 6 A and B) . A higher proportion of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes were apoptotic in the chimeras at all points beyond the DN stage (Fig. 6A) . The single loss of either Akt1 or Akt2 also resulted in slightly more apoptosis at the CD8 ϩ /immature SP stage (Fig. 6A) . We also found an increasing pattern of apoptosis in thymocytes from newborn pups that lacked two, three, or four alleles of Akt (Fig. 6B) . The loss of three or four Akt alleles correlated with a higher percentage of apoptotic cells at the TCR␤ hi and TCR␤ int stages of development. Based on this pattern of apoptosis, we hypothesized that post-DN3 cells may require Akt for survival upon TCR stimulation.
To test whether the absence of Akt in immature thymocytes causes apoptosis with pre-TCR stimulation, cells from day 10 OP9-DL1 cultures were stimulated with ␣CD3 and ␣CD28 to mimic ␤-selection. In contrast to cells expressing even a single copy of Akt1 or Akt2, Akt1
Akt2
Ϫ/Ϫ cells exhibited increased cell death with pre-TCR stimulation (Fig. 6C) . Additionally, Akt1 Ϫ/ ϪAkt2 Ϫ/Ϫ DN3 cells were more susceptible to death by neglect and lost a greater percentage of cell size before death compared with controls ( Fig. 6D and SI Fig. 10B ). In contrast, Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ DN3 cells were equally sensitive to dexamethasone-induced apoptosis (data not shown). Taken together, these data indicate that the combined loss of Akt1 and Akt2 causes increased apoptosis in immature thymocytes after expression of the TCR␤ chain but a comparably modest effect on proliferation during the DN3 to DP transition.
Discussion
Akt isoforms are known modulators of four essential processes in multiple cell types: cell growth, metabolism, proliferation, and survival (4). Here, using several complementary approaches, we show that Akt1 and Akt2 are required for successful passage through the DN3 to DP transition in the thymus. Using mice deficient in Akt1, Akt2, or both, we find that there is a trend toward decreased thymic cellularity with the loss of Akt1 alone but a striking defect in development when both Akt1 and Akt2 are absent. Although Akt1 and Akt2 are expressed earlier in development, we find no defects before the DN3 stage, suggesting that events that are initiated by the newly formed pre-TCR are those that rely most heavily on Akt1 and Akt2. Our proposed mechanism for this altered thymic development is a combination of decreased metabolic capacity at the DN3 stage, when pre-TCR formation requires increased metabolism for the subsequent proliferative burst, and increased apoptosis of these metabolically unprepared cells. The increased apoptosis found in the absence of Akt1 and Akt2 corroborates results from multiple studies in which the PI3K-PTEN-Akt signaling pathway has been perturbed. The expression of a dominant negative PI3K in human thymocyte progenitors leads to decreased cellularity in fetal thymic organ cultures, yet it was not determined whether this outcome was due to a defect in proliferation or survival (20) . Additionally, the targeted deletion of the genes for the catalytic subunits of PI3K also caused increased apoptosis in the DP stage with no effect on proliferation (10). PDK1, an activating kinase of Akt, is also required to maintain normal thymic cellularity, as loss of PDK1 results in a developmental block at the DN3 to DP transition, although no direct evidence for increased apoptosis was detected (21) . Complementing these studies of diminished Akt function, myr-Akt1 increases cell survival in response to multiple apoptotic stimuli (19) . Similarly, the loss of PTEN, a phosphatase that interferes with Akt activation, rescued development in the absence of the CD3␥ chain, a component of the pre-TCR (22) . Finally, we have preliminary data demonstrating that myr-Akt1 rescues the differentiation of T cells that are blocked at the DN3 stage because of loss of SLP-76 (3), a key adaptor molecule downstream of the pre-TCR (M.M.J. and G.A.K., unpublished data).
Although pre-TCR signaling results in several critical events at the ␤-selection checkpoint, our data support a model in which Akt1 and Akt2 are required for the rescue of pre-TCR induced cell death. The data presented herein suggest that the proliferative response itself is only mildly decreased by Akt loss, consistent with previous studies demonstrating distinct pathways for survival versus proliferation at the ␤-selection checkpoint (2) . Signaling by the pre-TCR has been shown to directly influence cell cycle regulation through activation of the Ras-MAPK pathway (23, 24) . Overexpression studies using myr-Akt show that activated Akt1 leads to enhanced Erk phosphorylation, providing evidence for cross-talk between the pathways (25) . Indeed, the pathways may converge on similar targets in the thymus (26) ; however, there is no evidence that the MAPK signaling pathway depends on Akt activation. The molecular mechanism that allows for the proliferative burst at the ␤-selection checkpoint likely integrates survival, mitotic, and metabolic signaling pathways. This model is consistent with our observation that Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes appropriately enter the cell cycle coincident with pre-TCR expression but are ultimately not protected from cell death.
Highly proliferative cells, such as those in the proliferative burst phase after ␤-selection, may be more prone to apoptosis to limit tissue expansion (27) . In the normal thymus, a mechanism may be present to inhibit apoptosis, allowing for continued proliferation and progression to the DP stage. Our data suggest that Akt1 and Akt2 are critical at this point to interdict the apoptotic pathway. Additionally, before the DN3 stage, survival and proliferative signals are pre-TCR independent, depending instead on the cytokine IL-7 (20) . Once cells reach the DP stage, they lack IL-7R␣ and depend instead on the pre-TCR for survival signals (28) . Although IL-7 also signals through Akt (20) , the normal development of Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes before the DN3 stage suggests that there may be redundancy with Akt3 or that there are parallel pathways from the IL-7R that lead to survival or proliferation.
Akt promotes cell survival through the direct phosphorylation of anti-apoptotic molecules or indirectly through the transcriptional activation of anti-apoptotic genes and increased metabolic capacity (4) . Mutations of several putative Akt target pathways, including NF-B (29) and GSK3␤ (30) , result in defective thymocyte survival similar to what we have found in this study. Finally, Akt1 but not Akt2 has been shown to directly phosphorylate CREB (31) , and CREB Ϫ/Ϫ mice have a paucity of TCR␤ hi cells and overall decreased thymic cellularity (32) . Additional studies are needed to determine whether these signaling molecules or possibly other candidates are the relevant targets of Akt at the DN3 to DP transition.
Although Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ cells showed increased apoptosis, they did not have decreased protein levels of Bcl-xL (19, data not shown), indicating that other Akt-dependent survival pathways may be responsible for altered survival. One means by which Akt protects cells from death is by control of glucose metabolism (4) through the combined increases in Glut1 surface expression and activity of the glucose transporter (8) . Akt also regulates enzymes within the glucose metabolic pathway, lipid metabolism, and mTOR-dependent protein translation (4). It is likely that one or several of these pathways is responsible for the observed increased apoptosis in the Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ thymocytes, as it has become clear that maintenance of normal glucose metabolism is critical for cell survival. In particular, failure to sustain glucose metabolism is associated with the loss of the anti-apoptotic Bcl-2 protein Mcl-1.
T cell stimulation leads to increased cellular metabolic and biosynthetic demands (33) . During ␤-selection, metabolic demand increases to provide enough substrates for the proliferative burst, and a failure to meet this demand may lead to apoptosis when the cell has exhausted its capacity to grow before division. In support of this model, we find that the actively cycling Akt1 Ϫ/Ϫ Akt2 Ϫ/Ϫ cells are smaller than their WT controls (data not shown). Our studies suggest that Akt1 and Akt2 play overlapping and required roles to promote thymocyte metabolism and survival following pre-TCR stimulation. Future studies will address how the metabolism and growth of Akt-deficient thymocytes are altered and how this alteration ultimately relates to the developmental abnormalities we observe.
Materials and Methods
Mice. Mice lacking Akt1 or Akt2 on the C57BL/6 background were described in refs. 34 and 35. SJL.B6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). All experiments were performed according to the guidelines of the University of Pennsylvania and Duke University Institutional Animal Care and Use Committees.
Flow Cytometric Analysis. Single cell suspensions from thymi, spleens, and OP9-DL1 cultures were stained in FACS buffer (PBS/2% FBS/azide) and analyzed on a FACSCalibur or an LSRII (BD Biosciences, San Jose, CA), using FlowJo software. Annexin V staining was completed by using the manufacturer's protocol (BD Biosciences) except for an additional wash before analysis. DAPI was used as a live/dead exclusion marker. Cells were sorted on a FACSVantage SE (BD Biosciences) based on the surface expression of Thy1.2, CD4, CD44, and CD25. The lineage mixture for DN subset analysis includes CD8, NK1.1, CD11b, GR-1, CD11c, TCR␥␦, B220, and Ter119. SI Materials and Methods contains further antibody information.
Statistical Analysis. Statistical analysis was performed with twotailed, unpaired Student's t tests with Prism software (significance: *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.0001).
Real-time PCR. TRIzol (Invitrogen, Carlsbad, CA)-isolated RNA was reverse transcribed with SuperScript II (Invitrogen). Quantitative RT-PCR was done by using SYBR Green Supermix (Bio-Rad, Hercules, CA) and was analyzed on an iCycler. All data were calculated relative to Akt1 levels in thymic CD4 SP cells and based on ␤2-microglobulin as the internal control. Primer sequences are available in SI Materials and Methods.
Biochemistry. Thymocytes were resuspended at 10 6 cells per 100 l in PBS, rested for 20 min at 37°C, and stimulated with 10 g/ml ␣CD3 (500A2-BD Biosciences). Cell lysates [RIPA buffer (36) ] were run on SDS/PAGE. Membranes were incubated with p-Akt S473 (BD Biosciences) or total Akt (BD Biosciences), were developed with ECL (Amersham, Little Chalfont, U.K.) or AlexaFluor-680 anti-rabbit IgG (Invitrogen) and IR Dye 800 anti-mouse IgG (Li-Cor Biosciences, Lincoln, NE), and were detected with a Li-Cor Odyssey system for the Akt1, Akt2, or Akt3 (Cell Signaling, Danvers, MA) Western blot. T cells were purified by using StemSep magnetic purification kits (StemCell Technologies, Vancouver, BC, Canada).
OP9-DL1 Cultures. Cultures were treated as described in ref. 37 , except Ϸ10 6 HSA-depleted (Miltenyi Biotec, Bergisch Gladbach, Germany) fetal liver cells (14.5-16.5 days post-coitum) were plated per well in a 24-well plate, and media were supplemented with 5 ng/ml each murine IL-7 and human Flt-3L (R&D Systems, Minneapolis, MN).
TCR Stimulation and Apoptosis Assays in Vitro.
Fetal liver cells were cultured with OP9-DL1 cells for 10 days and passed into 96-well plates containing OP9-DL1 cells. Cultures were stimulated with 20 g/ml each ␣CD3 and ␣CD28 (BD Biosciences) in the presence of IL-7 and Flt-3L (described above). For neglect conditions, cells were plated without OP9-DL1 cells or cytokines. After 24-30 h, cell viability was defined by PI exclusion and cell size (FACScan).
Bone Marrow Chimeras. Fetal livers were harvested from embryos 14.5-16.5 days postcoitum and were cultured overnight in ␣MEM supplemented with 20% FBS, 2.2 g/liter sodium bicarbonate, 2 mM glutamine, antibiotics, 10 ng/ml IL-6 (Peprotech), 20 ng/ml IL-3 (Peprotech), and 100 g/ml stem cell factor (Peprotech, Rocky Hill, NJ). Embryos were genotyped by PCR amplification, and 0.25 ϫ 10 6 cells were injected into irradiated SJL.B6 mice (550 rads, two doses, 4 h apart).
Glucose Uptake. Fetal liver cells cultured with OP9-DL1 cells for 10 days were resuspended in 0.5% BSA in Kreb's Ringers buffer. Uptake of 3 H-2-deoxy-D-glucose (Amersham) was measured as described in ref. 8 , using 2 Ci per reaction with a 10 min incubation.
In Vivo BrdU Labeling. Mice were injected i.p. with 2 mg/200 l of BrdU (BD Biosciences), and thymi were harvested 5 h later. The protocol for the BrdU kit (BD Biosciences) was followed except for the use of DAPI as marker for DNA content.
Note Added in Proof. While this manuscript was under review, another group also reported the importance of Akt isoforms in thymic development (38) .
